Attenuation of Aβ-induced apoptosis of plant extract (Saengshik) mediated by the inhibition of mitochondrial dysfunction and antioxidative effect

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 399-411

  Chen, Chu Yue ^a   Jang, Jung Hee ^a   Mi, Hyun Park ^b   Sung, Joo Hwang ^b   Surh, Young Joon ^a   Ock, Jin Park ^c  

^a Seoul National University   (South Korea)

^b Eromlife Cooporation   (South Korea)

^c Hannam University   (South Korea)

Author keywords

Alzheimer's disease; Antioxidant capacity; Neuroprotective effects; PC12 cells; Saengshik

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; AMYLOID BETA PROTEIN; CASPASE 3; GLUTATHIONE; MALONALDEHYDE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SAENGSHIK; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOACCUMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; IN VITRO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT; ALZHEIMER DISEASE; ANIMAL; ARTICLE; CELL STRAIN; CELL SURVIVAL; DIET THERAPY; DRUG ANTAGONISM; HEALTH FOOD; PHYSIOLOGY;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL SURVIVAL; HEALTH FOOD; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; PC12 CELLS; PLANT EXTRACTS; RATS;

EID: 34247854890     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.043     Document Type: Conference Paper

References (28)

1. KEHRER, J.P. 1993. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23: 21-48.
2. TRUSH, M.A., E.C. MINMAUGH & T.E. GRAM. 1982. Activation of pharmacologic agents to radical intermediates: implications for the role of free radicals in drug action and toxicity. Biochem. Pharmacol. 31: 3335-3346.
3. OLANOW, C.M. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci. 16: 439-444.
4. MARKESBERY, W.R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Rad. Biol. Med. 23: 134-147.
5. BERNARDI, P. 1966. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275: 5-9.
6. CHAKRABORATI, T., S. DAS, M. MONDAL, et al. 1999. Oxidant, mitochondria and calcium: an overview. Cell Signal. 11: 77-85.
7. SATOH, T., Y. ENOKIDO, H. AOSHIMA & Y. UCHIAMA. 1997. Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J. Neuro. Res. 50: 413-420.
8. HOYT, K.R., A.J. GALAGHER, T.G. HASTINGS & I.J. REYNOLDS. 1997. Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem. Res. 22: 333-340.
9. HARDY, J.A. & G.A. HIGGINS. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 257: 184-185.
10. BURDON, R.H. 1999. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad. Biol. Med. 31: 261-272.
11. TEMPLE, N.J. 2000. Antioxidants and disease: more question than answers. Nutr. Res. 20: 449-459.
12. BURDON, R.H. 1996. Control of cell proliferation by reactive oxygen species. Biochem. Soc. Transac. 24: 1028-1032.
13. BEHL, C., J. DAVIS, G.M. COLE & D. SCHUBERT. 1992. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-950.
14. PAPPOLLA, M.A., Y.J. CHYAN, B. POEGGELER, et al. 2000. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. Neural Transm. 107: 203-231.
15. GSELL, W., R. CONRAD, M. HICKETHIER, et al. 1995. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64: 1216-1223.
16. AKSENOV, M.Y., H.M. TUCKER, P. NAIR, et al. 1998. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J. Mol. Neurosci. 11: 151-164.
17. LOO, D.T., A. COPANI, C.J. PIKE, et al. 1993. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90: 7951-7955.
18. ALLEN, J.W., B.A. ELDADAH, X. HUANG, et al. 2001. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J. Neurosci. Res. 65: 45-53.
19. STELLER, H. 1995. Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
20. GLENNER, G.G. 1989. Amyloid beta protein and the basis for Alzheimer's disease. Prog. Clin. Biol. Res. 317: 857-868.
21. BRAAK, H. & E. BRAAK. 1997. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol. Aging 18: S85-S88.
22. HAASS, C. 1997. Presenilins: genes for life and death. Neuron 18: 687-690.
23. HARDY, J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20: 154-159.
24. ORTH, M. & A.H.V. SCHAPIRA. 2002. Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40: 533-541.
25. OLNEY, J.W. 2002. Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr. Opin. Pharmacol. 3: 1-9.
26. SIAN, J., D.T. DEXTER, S.E. DANIEL, et al. 1994. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann. Neurol. 36: 348-355.
27. ZEEVALK, G.D., L.P. BERNARD, D.S. ALBERS, et al. 1997. Energy stress-induced dopamine loss in glutathione-depleted mesencephalic cultures. J. Neurochem. 68: 426-429.
28. PEREIRA, C.F. & C.R. OLIVERIRA. 2000. Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis. Neurosci. Res. 37: 227-236.